You’ll gain exclusive access to the nation’s most protected inventory of shortage-prone drugs through Novaplus®, our private label. Unique in the industry, Novaplus features a mostly injectable portfolio, which has been increasing by about two dozen new drugs each year since 2012. Fill rates average 92%, which is significantly higher than the 79% average by other group purchasing organizations (GPOs).
PHARMACY PROGRAM OVERVIEW
JUST WHAT THE DOCTOR ORDERED
We do the work to ensure minimal disruption during supply shortages.
THE POWER OF MANY
We aggregate purchasing power across our membership to drive savings
Connect with other pharmacy leaders and always stay in the know.
DATA DRIVEN DECISIONS
Gain access to real-time data and give you the information needed for better decision making.
SUBJECT MATTER EXPERTS
Get market insights from our experts to better inform your business.
We work with you to customize an integration and business plan that best serves your patients.
NOvAPLUS MAKES THE PROVISTA PROGRAM UNIQUE
Novaplus offers more almost 200 drugs representing approximately 877 national drug codes (NDCs) including antibiotics, anesthesia and oncology pharmaceuticals.
- Add approx. 24 new drugs/year since 2012
- Primarily a generic injectable portfolio
- Competitive upfront pricing
- Offers unique access to products not on contract with other group purchasing organizations (GPOs) and exclusive discounts not available anywhere else
- Dedicated inventory helps insulate members from industry shortages
- Clear labeling guidelines to protect against look-alike pharmaceuticals
- 90%+ aggregate compliance rate
- $18 million in quarterly standardization rebates
Both labels are part of the Novaplus Program and count toward standardization rebates
Different NDCs, same manufacturer, different labels
Ready to Get Started?
Take the next step to start saving.Become a Member